GSK bets $2 billion on Bellus cough drug to soothe pipeline fears
GSK bets $2 billion on Bellus cough drug to soothe pipeline fears By Natalie Grover and Aby Jose Koi...
18th April, 2023
GSK bets $2 billion on Bellus cough drug to soothe pipeline fears By Natalie Grover and Aby Jose Koi...
18th April, 2023
Ericsson’s quarterly core profit misses expectations STOCKHOLM (Reuters) -Sweden’s Ericsson on Tuesd...
18th April, 2023
Manchester United tanks on report Glazers may avoid sale with new investment (Reuters) – Shares of M...
18th April, 2023
Glencore courts 120 Teck investors for bid backing as spinoff vote looms -source LONDON (Reuters) -G...
18th April, 2023
For over 20 years, U.S. Money Reserve has been a leading distributor of government-issued precious m...
17th April, 2023
Agnellis’ Exor eyes further healthcare investment for expansion By Giulio Piovaccari MILAN (Reuters)...
17th April, 2023
Shareholder group ISS backs Barclays board over former CEO Staley By Sinead Cruise LONDON (Reuters)...
17th April, 2023
Sega Sammy says it is considering buying Angry Birds maker Rovio TOKYO (Reuters) – Japan’s Sega Samm...
17th April, 2023
Volkswagen to partner on Indonesia EV battery ecosystem -minister JAKARTA (Reuters) – Volkswagen wil...
17th April, 2023
France’s Ynsect to refocus bug business after capital increase By Sybille de La Hamaide PARIS (Reute...
17th April, 2023
Soccer-Jittery Arsenal losing their grip with summit in sight By Martyn Herman LONDON (Reuters) -Eve...
17th April, 2023
Tesla expands discounts with price cuts in Europe, Singapore, Israel By Chen Lin and Victoria Walder...
14th April, 2023